3.0.0
280
2023-01-11T13:47:55Z
2023-01-11T13:47:55Z
House
HRES
2021-03-26
117
- hsif00
Energy and Commerce Committee
House
Standing
  - hsif14
Health Subcommittee
    - Referred to
2021-03-29T15:33:18Z
  - Referred to
2021-03-26T18:07:45Z
- hsfa00
Foreign Affairs Committee
House
Standing
  - Referred to
2021-03-26T18:07:40Z
- hswm00
Ways and Means Committee
House
Standing
  - hswm04
Trade Subcommittee
    - Referred to
2021-03-26T16:53:04Z
  - Referred to
2021-03-26T18:07:35Z
- 2021-03-29
  - hsif14
Health Subcommittee
1
House committee actions
Referred to the Subcommittee on Health.
Committee
- 2021-03-26
Referred to the Committee on Ways and Means, and in addition to the Committees on Foreign Affairs, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2
House floor actions
  - hsif00
Energy and Commerce Committee
- 2021-03-26
Referred to the Committee on Ways and Means, and in addition to the Committees on Foreign Affairs, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2
House floor actions
  - hsfa00
Foreign Affairs Committee
- 2021-03-26
Referred to the Committee on Ways and Means, and in addition to the Committees on Foreign Affairs, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2
House floor actions
  - hswm00
Ways and Means Committee
- 2021-03-26
  - hswm04
Trade Subcommittee
1
House committee actions
Referred to the Subcommittee on Trade.
Committee
- 2021-03-26
Introduced in House
IntroReferral
Intro-H
9
Library of Congress
- 2021-03-26
Introduced in House
IntroReferral
1000
9
Library of Congress
- J000304
Rep. Jackson, Ronny [R-TX-13]
Ronny
Jackson
R
TX
13
N
- B001299
Rep. Banks, Jim [R-IN-3]
Jim
Banks
R
IN
3
2021-03-26
True
- F000472
Rep. Franklin, C. Scott [R-FL-15]
C.
Franklin
R
FL
Scott
15
2021-03-26
True
- H001084
Rep. Herrell, Yvette [R-NM-2]
Yvette
Herrell
R
NM
2
2021-03-26
True
- M001199
Rep. Mast, Brian J. [R-FL-18]
Brian
Mast
R
FL
J.
18
2021-03-26
True
- B001307
Rep. Baird, James R. [R-IN-4]
James
Baird
R
IN
R.
4
2021-03-26
True
- T000478
Rep. Tenney, Claudia [R-NY-22]
Claudia
Tenney
R
NY
22
2021-03-26
True
- H001071
Rep. Hice, Jody B. [R-GA-10]
Jody
Hice
R
GA
B.
10
2021-03-26
True
- S000168
Rep. Salazar, Maria Elvira [R-FL-27]
Maria
Salazar
R
FL
Elvira
27
2021-03-26
True
- M001177
Rep. McClintock, Tom [R-CA-4]
Tom
McClintock
R
CA
4
2021-03-26
True
- R000614
Rep. Roy, Chip [R-TX-21]
Chip
Roy
R
TX
21
2021-03-26
True
- H001086
Rep. Harshbarger, Diana [R-TN-1]
Diana
Harshbarger
R
TN
1
2021-04-01
False
- C001051
Rep. Carter, John R. [R-TX-31]
John
Carter
R
TX
R.
31
2021-04-13
False
- R000609
Rep. Rutherford, John H. [R-FL-4]
John
Rutherford
R
FL
H.
4
2021-04-13
False
- S000929
Rep. Spartz, Victoria [R-IN-5]
Victoria
Spartz
R
IN
5
2021-06-08
False
Foreign Trade and International Finance
- Administrative law and regulatory procedures
- Asia
- China
- Competition and antitrust
- Competitiveness, trade promotion, trade deficits
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Food and Drug Administration (FDA)
- Free trade and trade barriers
- Government information and archives
- Health technology, devices, supplies
- Manufacturing
- Prescription drugs
- Trade agreements and negotiations
Foreign Trade and International Finance
00
2021-03-26
Introduced in House
2021-04-16T17:24:50Z
This resolution commits to the use of competitive free market and free trade policies to combat national security threats caused by China and its attacks on the U.S. pharmaceutical manufacturing base.
The resolution urges the United States to (1) remove tax, regulatory, and debt burdens and barriers that have weakened this base; (2) empower the U.S. Trade Representative to take specified actions to counter harmful and unfair trade practices by China; (3) address shortcomings in Food and Drug Administration data collection related to foreign-sourced pharmaceutical ingredients; and (4) identify and streamline regulatory hurdles that have impeded the U.S. pharmaceutical manufacturing base.

Expressing the sense of the House of Representatives that decades of policies rooted in socialism have stifled United States domestic pharmaceutical drug manufacturing and left the United States exposed to the hostile actions and unfair trade practices of the People's Republic of China.
- Display Title

Expressing the sense of the House of Representatives that decades of policies rooted in socialism have stifled United States domestic pharmaceutical drug manufacturing and left the United States exposed to the hostile actions and unfair trade practices of the People's Republic of China.
- Official Title as Introduced

Expressing the sense of the House of Representatives that decades of policies rooted in socialism have stifled United States domestic pharmaceutical drug manufacturing and left the United States exposed to the hostile actions and unfair trade practices of the People's Republic of China.
Introduced in House
IH
- Introduced in House
2021-03-26T04:00:00Z
  - https://www.govinfo.gov/content/pkg/BILLS-117hres280ih/xml/BILLS-117hres280ih.xml
2021-03-29
Referred to the Subcommittee on Health.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.